SAN RAMON, Calif.—CooperVision has named Jane Agbontaen as senior brand director for myopia management–Americas, according to an announcement this week. In this newly created role, Agbontaen will be responsible for the strategic planning and execution of all activities that support the U.S. growth of CooperVision’s myopia management portfolio—specifically the Brilliant Futures Myopia Management Program with MiSight 1 day, the first and only FDA-approved product clinically proven to slow the progression of myopia when initially prescribed for children 8-12 years old in the U.S.

CooperVision announced the launch of the Brilliant Futures Myopia Management Program earlier this month, as VMAIL reported. 

Agbontaen’s role includes cross-functional and cross-business support to ensure CooperVision’s MiSight 1 day commercialization strategy is successful. Growing the portfolio includes touchpoints with eyecare practitioners and patients, as well as health care and legislative ecosystems that govern children’s health and wellness.

“With the FDA approval of MiSight and the impending roll out of our Brilliant Futures Myopia Management Program, we require an evolution of our sales and marketing approach as we take on the rising epidemic of childhood myopia,” vice president of marketing at CooperVision, North America, Simon Seshadri said in the announcement.

“Going forward, broadening our scope of health care provider alliances and industry partnerships are essential elements of shaping the standard of care in myopia management. Jane’s previous experiences and skills are a perfect fit for this role and to help us achieve our desired outcomes. I’m delighted to have her onboard.”

Agbontaen has more than 20 years of professional experience in health care and with large medical device players, including Hologic, Abbott Medical Optics and Johnson & Johnson DePuy Synthes. While at Abbott Medical Optics, which was acquired by Johnson & Johnson Vision Care during her tenure, Agbontaen managed a broad brand portfolio in the cataracts segment, including intraocular lenses and instruments.

Agbontaen received her bachelor’s degree from Long Island University and her MBA from the Stern School at New York University, according to the announcement.